The elimination of a key C.D.C. office has slashed funding to states for help lines used by thousands to stop smoking and vaping.
Category: Food and Drug Administration
-
F.D.A. Scientists Are Reinstated at Agency Food Safety Labs
After 20 percent of the agency’s work force was cut, federal health officials have decided to bring back some experts and review firings to fill gaps in critical roles.
-
RFK Jr. Wants to Ban Chemical Dyes. Food Makers Are in No Hurry.
Companies make packaged food without synthetic dyes in other countries. But despite pressure from Robert F. Kennedy Jr., the change isn’t likely to happen quickly in the United States.
-
Patients Cut Off From Cheaper Obesity Drugs as FDA Halts Sales of Copycats
U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or suspend treatment for patients.
-
Trump Seeks to Lower Drug Prices Through Medicare and Some Imports
President Trump directed his administration to help states import drugs from Canada. But a proposal to alter a Medicare program to reduce costs could wind up raising prices.
-
RFK Jr. Accuses FDA of Drug Industry Influence That Barred Alternative Remedies
The nation’s health secretary addressed agency employees, asking them to shed any corporate influence. But he did not address the mass layoffs that have gutted oversight of tobacco and vapes, food safety and drug reviews.
-
Cabot Creamery Butter Is Recalled Over Fecal Contamination Risk
The company said it was voluntarily recalling 189 cases of its eight-ounce, sea-salted Extra Creamy Premium Butter after it found elevated levels of coliform bacteria.
-
Trump’s Next Tariffs Target Could be Foreign-Made Pharmaceuticals
President Trump wants to bring pharmaceutical manufacturing back to the United States. Experts warn that tariffs could result in shortages and higher prices for generic drugs.
-
FDA Layoffs Could Raise Drug Costs and Erode Food Safety
Trump cutbacks were supposedly aimed at administrators. But scientists in food and drug-testing labs and policy experts who advance generic drug approvals were also dismissed.
-
Federal Workers Walk Into Chaos Amid Return to Office
President Trump has described his new in-office requirement as a way to ensure workers are doing their jobs. He sees potentially leading more employees to quit as an added benefit.
-
Is the Poppers Party Over?
A potential crackdown on a readily available party drug seems to be afoot. But don’t panic just yet.